EUVIMEDEUVIMED entdecken
Crossref

Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin

Nina Kleditzsch, James J Gattuso iD, Anthony J Hannan iD, Thibault Renoir iD

European Journal of Neuroscience · 2025

DOI: 10.1111/ejn.70351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2025. Verfasst von Nina Kleditzsch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Psilocybin, Serotonin Plasma Membrane Transport Proteins, Hallucinogens, Escitalopram. Die Arbeit nennt 40 Literaturangaben. Gefördert von: SUND Outgoing Mobility Grant provided by the Faculty of Health and Medical Sciences, University of Copenhagen, Medicine, Density and Health Science graduate research scholarship, Principal Research Fellowship, Project Grants and an Ideas Grant from the National Health and Medical Research Council (NHMRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The psychedelic psilocybin has gained popularity in recent years as a therapy for treatment‐resistant depression and has been reported to reduce symptoms of depression and anxiety. Psilocybin's active metabolite, psilocin, possesses a binding affinity for serotonin receptors as well as for the serotonin transporter (5‐HTT). We recently reported that in contrast to wild‐type mice, psilocybin did not induce hyperlocomotion and head‐twitch responses in mice genetically lacking 5‐HTT, suggesting an involvement of 5‐HTT in mediating these effects. To further assess the specific role of 5‐HTT in psilocybin's acute behavioural effects, we treated C57BL/6 mice with the highly selective 5‐HTT inhibitor escitalopram (2.5–5 mg/kg, i.p.) prior to psilocybin administration (1 mg/kg, i.p.), and measured acute behavioural effects including head‐twitch response and locomotor activity. We found that acute psilocybin administration increased locomotor activity and induced head twitches, and that escitalopram did not alter these effects. Our study using low doses of escitalopram reveals no direct involvement of 5‐HTT in mediating the acute effects of psilocybin in mice, and instead suggests that developmental changes and varying serotonin levels may rather explain the absence of psilocybin's acute behavioural effects previously reported in the 5‐HTT homozygous knockout mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsilocybinSerotonin Plasma Membrane Transport ProteinsHallucinogensEscitalopramBehavior, AnimalSelective Serotonin Reuptake InhibitorsCitalopramAnimalsMiceMice, Inbred C57BLMaleLocomotion

Stichwörter der Autor:innen

head‐twitch responsepsilocybinserotonin transporter

Substanzen

PsilocybinSerotonin Plasma Membrane Transport ProteinsHallucinogensEscitalopramSelective Serotonin Reuptake InhibitorsCitalopram

Autor:innen und Institutionen

  • Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, University of Melbourne, Parkville, Australia.
  • Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia.

ORCID-Profile: James J Gattuso, Anthony J Hannan, Thibault Renoir

Förderung

  • SUND Outgoing Mobility Grant provided by the Faculty of Health and Medical Sciences, University of Copenhagen
  • Medicine, Density and Health Science graduate research scholarship
  • Principal Research Fellowship, Project Grants and an Ideas Grant from the National Health and Medical Research Council (NHMRC)
  • DHB Foundation (Equity Trustees)
  • Ronald Philip Griffiths Fellowship from the University of Melbourne
  • Victorian Government's Operational Infrastructure Support Grant
  • Equity Trustees

Zitieren

APA

Kleditzsch, N., Gattuso, J. J., Hannan, A. J., & Renoir, T. (2025). Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin. European Journal of Neuroscience. https://doi.org/10.1111/ejn.70351

Vancouver

Kleditzsch N, Gattuso JJ, Hannan AJ, Renoir T. Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin. European Journal of Neuroscience. 2025. doi:10.1111/ejn.70351

BibTeX
@article{Kleditzsch2025,
  author = {Kleditzsch, Nina and Gattuso, James J and Hannan, Anthony J and Renoir, Thibault},
  title = {Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin},
  journal = {European Journal of Neuroscience},
  year = {2025},
  doi = {10.1111/ejn.70351}
}
Kostenlos starten →